Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

BETAPACE- sotalol hydrochloride tabletBETAPACE AF- sotalol hydrochloride tablet

  1. Patient Information
  2. Manufactured For:

Patient Information 

Advise patients to contact their health care provider in the event of syncope, pre-syncopal symptoms or cardiac palpitations.
Advise patients that their electrolytes and ECG will be monitored during treatment[see Warnings and Precautions (5.1)].
Advise patients to contact their healthcare provider in the event of conditions that could lead to electrolyte changes such as severe diarrhea, unusual sweating, vomiting, less appetite than normal or excessive thirst[see Warnings and Precautions (5.1)].
Advise patients not to change the Betapace/Betapace AF dose prescribed by their healthcare provider.
Advise patients that they should not miss a dose, but if they do miss a dose they should not double the next dose to compensate for the missed dose: they should take the next dose at the regularly scheduled time[see Dosage and Administration (2)].
Advise patients to not interrupt or discontinue Betapace/Betapace AF without their physician s advice, that they should get their prescription for sotalol filled and refilled on time so they do not interrupt treatment[see Dosage and Administration (2)].
Advise patients to not start taking other medications without first discussing new medications with their healcare provider.
Advice patients that they should avoid taking Betapace/Betapace AF within two hours of taking antacids that contain aluminum oxide or magnesium hydroxide[see Drug Interactions (7.7)].

2016, Covis Pharma. All rights reserved.

Manufactured For: 

Covis Logo

Covis Pharma
Zug, 6300 Switzerland

Rev. 05/2016

Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: